The closure of the unit is part of a broader reorganization and series of layoffs announced in August. The 1,000-person layoffs are part of a strategy to save the company $700 million by 2025.
Additionally, Biogen is ending a clinical trial partnership with Apple early. The company said that it will still look for tech startup partnerships in the future.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
